SO-28 A randomized phase II trial of mFOLFOX6-based standard of care alone or in combination with Ad-CEA vaccine plus avelumab in patients with previously untreated metastatic colorectal cancer

Subjects

Subjects :

Oncology
medicine.medical_specialty
Standard of care
Colorectal cancer
business.industry
Hematology
CEA Vaccine
medicine.disease
Avelumab
Internal medicine
medicine
In patient
business
medicine.drug

Details

ISSN :

09237534

Volume :

31

Database :

OpenAIRE

Journal :

Annals of Oncology

Accession number :

edsair.doi...........a9c702f9077dea7b4f513394fceae04c

Full Text :

https://doi.org/10.1016/j.annonc.2020.04.043